Product Code: ETC13158612 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Pertussis Market was valued at USD 5 Billion in 2024 and is expected to reach USD 6.5 Billion by 2031, growing at a compound annual growth rate of 5.90% during the forecast period (2025-2031).
The global pertussis market is characterized by the increasing prevalence of whooping cough, particularly in infants and children, driving the demand for pertussis vaccines and treatments. The market is witnessing growth due to the expanding immunization programs and awareness initiatives by healthcare organizations and governments worldwide. Key market players are focusing on developing advanced vaccines with improved efficacy and fewer side effects to address the rising concerns related to pertussis outbreaks. Additionally, collaborations between pharmaceutical companies and healthcare institutions for research and development activities are expected to further propel market growth. The market is also influenced by regulatory guidelines for vaccination schedules and the introduction of new formulations, contributing to the overall market dynamics and competitive landscape in the global pertussis market.
The global pertussis market is witnessing a growing focus on the development of improved vaccines and diagnostic tools for the prevention and early detection of this highly contagious respiratory disease. With increasing awareness about the importance of vaccination in preventing pertussis outbreaks, there is a rising demand for more effective and long-lasting vaccines. Additionally, the emergence of advanced molecular diagnostic technologies presents opportunities for the development of rapid and accurate diagnostic tests for pertussis. The market is also witnessing collaborations between pharmaceutical companies and research institutions to accelerate the development of novel treatments and vaccines. Overall, the global pertussis market is poised for growth driven by advancements in vaccine technologies and diagnostics, along with the increasing emphasis on disease prevention and control.
The Global Pertussis Market faces several challenges, including limited awareness about the disease leading to underdiagnosis and underreporting, especially in developing countries. Additionally, the availability and accessibility of pertussis vaccines in some regions remain inadequate, contributing to the persistence of the disease. The emergence of new pertussis strains and the waning immunity from existing vaccines further complicate efforts to control and prevent outbreaks. High costs associated with the development of new vaccines and the lack of universal vaccination programs in many countries also hinder market growth. Addressing these challenges will require collaborative efforts among healthcare providers, policymakers, and pharmaceutical companies to improve disease surveillance, increase vaccine coverage, and develop more effective and affordable pertussis vaccines.
The global pertussis market is primarily driven by the increasing awareness about the disease and the importance of vaccination, leading to a growing demand for pertussis vaccines. Additionally, the rising prevalence of pertussis, particularly among infants and young children, is a key factor driving market growth. Government initiatives and immunization programs aimed at controlling the spread of pertussis are also contributing to market expansion. Furthermore, advancements in vaccine development and increasing healthcare expenditure in developing regions are expected to fuel market growth in the coming years. Overall, the increasing focus on preventing and managing pertussis cases worldwide is propelling the growth of the global pertussis market.
Government policies related to the Global Pertussis Market primarily focus on prevention through vaccination programs, surveillance, and research funding. Many governments mandate pertussis vaccination for infants and children as part of routine immunization schedules to reduce the incidence of the disease. Additionally, governments support surveillance systems to monitor pertussis cases and outbreaks, enabling timely response and control measures. Research funding is allocated to develop new vaccines, improve existing ones, and enhance diagnostic tools for pertussis. Regulatory agencies play a crucial role in ensuring the safety and efficacy of pertussis vaccines on the market. Overall, government policies aim to prevent the spread of pertussis, protect vulnerable populations, and promote public health through a comprehensive approach involving vaccination, surveillance, and research initiatives.
The Global Pertussis Market is expected to see steady growth in the coming years due to the increasing awareness about the disease and the importance of vaccination. The rising prevalence of pertussis, particularly among infants and young children, is driving the demand for diagnostic tests, vaccines, and treatment options. Technological advancements in diagnostic tools and vaccine development are also anticipated to positively impact market growth. Additionally, government initiatives and healthcare programs aimed at preventing the spread of pertussis are likely to further boost market expansion. However, challenges such as vaccine hesitancy and limited access to healthcare in certain regions could hinder market growth to some extent. Overall, the Global Pertussis Market is projected to grow as efforts to control and prevent the disease continue to gain momentum.
In the global pertussis market, North America and Europe are the leading regions due to high awareness about vaccination programs and advanced healthcare infrastructure. Asia Pacific is expected to witness significant growth in the coming years, driven by increasing government initiatives to control the spread of pertussis and rising healthcare expenditure. The Middle East and Africa region are also projected to show growth, supported by improving healthcare facilities and growing awareness about vaccination. Latin America is expected to exhibit moderate growth, attributed to the increasing focus on preventive healthcare measures and rising healthcare investments. Overall, the global pertussis market is forecasted to grow steadily across all regions, with varying degrees of growth potential and market dynamics in each region.
Global Pertussis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Pertussis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Pertussis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Pertussis Market - Industry Life Cycle |
3.4 Global Pertussis Market - Porter's Five Forces |
3.5 Global Pertussis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Pertussis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Global Pertussis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Global Pertussis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Pertussis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Global Pertussis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Pertussis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Pertussis Market Trends |
6 Global Pertussis Market, 2021 - 2031 |
6.1 Global Pertussis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Pertussis Market, Revenues & Volume, By Blood Tests, 2021 - 2031 |
6.1.3 Global Pertussis Market, Revenues & Volume, By Chest X-Ray, 2021 - 2031 |
6.1.4 Global Pertussis Market, Revenues & Volume, By Nose or Throat Culture & Test, 2021 - 2031 |
6.1.5 Global Pertussis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Pertussis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Pertussis Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.2.3 Global Pertussis Market, Revenues & Volume, By Vaccination, 2021 - 2031 |
6.2.4 Global Pertussis Market, Revenues & Volume, By Supportive Treatments, 2021 - 2031 |
6.2.5 Global Pertussis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Pertussis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Pertussis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Global Pertussis Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.3.4 Global Pertussis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Pertussis Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Pertussis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Pertussis Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.4 Global Pertussis Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.4.5 Global Pertussis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Pertussis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Pertussis Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Global Pertussis Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.5.4 Global Pertussis Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 North America Pertussis Market, Overview & Analysis |
7.1 North America Pertussis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Pertussis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Pertussis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Pertussis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Pertussis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Pertussis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.4 North America Pertussis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.5 North America Pertussis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Pertussis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7 North America Pertussis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Pertussis Market, Overview & Analysis |
8.1 Latin America (LATAM) Pertussis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Pertussis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Pertussis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Pertussis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Pertussis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Pertussis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Pertussis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.4 Latin America (LATAM) Pertussis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.5 Latin America (LATAM) Pertussis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Pertussis Market, Revenues & Volume, By End User, 2021 - 2031 |
8.7 Latin America (LATAM) Pertussis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Pertussis Market, Overview & Analysis |
9.1 Asia Pertussis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Pertussis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Pertussis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Pertussis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Pertussis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Pertussis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Pertussis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.4 Asia Pertussis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.5 Asia Pertussis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Pertussis Market, Revenues & Volume, By End User, 2021 - 2031 |
9.7 Asia Pertussis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Pertussis Market, Overview & Analysis |
10.1 Africa Pertussis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Pertussis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Pertussis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Pertussis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Pertussis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Pertussis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Pertussis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.4 Africa Pertussis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.5 Africa Pertussis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Pertussis Market, Revenues & Volume, By End User, 2021 - 2031 |
10.7 Africa Pertussis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Pertussis Market, Overview & Analysis |
11.1 Europe Pertussis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Pertussis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Pertussis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Pertussis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Pertussis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Pertussis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Pertussis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.4 Europe Pertussis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.5 Europe Pertussis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Pertussis Market, Revenues & Volume, By End User, 2021 - 2031 |
11.7 Europe Pertussis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Pertussis Market, Overview & Analysis |
12.1 Middle East Pertussis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Pertussis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Pertussis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Pertussis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Pertussis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Pertussis Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.4 Middle East Pertussis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.5 Middle East Pertussis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Pertussis Market, Revenues & Volume, By End User, 2021 - 2031 |
12.7 Middle East Pertussis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Pertussis Market Key Performance Indicators |
14 Global Pertussis Market - Export/Import By Countries Assessment |
15 Global Pertussis Market - Opportunity Assessment |
15.1 Global Pertussis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Pertussis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.3 Global Pertussis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.4 Global Pertussis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Pertussis Market Opportunity Assessment, By End User, 2021 & 2031F |
15.6 Global Pertussis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Pertussis Market - Competitive Landscape |
16.1 Global Pertussis Market Revenue Share, By Companies, 2024 |
16.2 Global Pertussis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |